The Contribution of Echocardiography in the Dysfunctions of Mechanical Prosthesis: Report of 11 Cases
Saloua Oummou*, Abir Abardazzou, Salwa Karimi, Dounia Benzeroual, Mustapha Elhattaoui
CHU Med VI, cardiology department of Marrakesh, Morocco
*Corresponding author: OUMMOU S and CHU Med VI, Cardiology Department of Marrakesh, Morocco, Email: dr.oummou@gmail.com
Received Date: 29 November, 2016; Accepted Date: 15 December, 2016; Published Date: 20 December, 2016
Introduction: The echocardiography has an essential place in the surveillance of prostheses. The aim of our study was to describe the echocardiography aspects of dysfunction of valvular prostheses.
Materials and methods: This is a retrospective study, which collected all patients admitted for dysfunction of mechanical prosthesis bileaflet in the cardiology department of Marrakech during a period of 2 years.
Results: We included 11 patients. The mean age was 43 years. Seven cases were carrying a mitral prosthesis, 3 patients with aortic prosthesis and one case a double valve. The average age of prostheses was 3.7years. All prosthesis was an ON-X type. The prosthesis dysfunction was revealed by an infectious syndrome (27%), acute heart failure (18%), ischemic stroke (18%), while 36% were asymptomatic. The Transthoracic Echocardiography (TTE) was pathological in 10
cases: a reduction in the functional surface prostheses with increased transprosthetic gradient (54%) significant par prosthetic leak (45%), a thrombus in one case, an anomaly of the movements of leaflet (18%). The Echo-Transesophageal (TEE) made in 8 patients, objectified images of thrombi (3 cases), Para prosthetic leaks (6 patients), abnormal of the movements of leaflet (4 cases).
Conclusion: Echocardiography is the gold standard for the diagnosis of prosthetic dysfunction with superiority of TEE over TTE.
Keywords: Dysfunction; Mechanical prosthesis bileaflet; Echocardiography; Valvular prosthesis; Mitral prosthesis.
Abbreviation:
DVI : Doppler Velocity Index
EOA : Effective Orifice Area
EROA : Effective Regurgitantorifice Area
LV : Left Ventricular
LVOT : Left Ventricular Outflow Tract
MPG : Mean Pressure Gradient
PHT : Pression Half Time
PHV : Prosthetic Heart Valves
R Vol : Regurgitant Volume
TEE : Transesophageal Echocardiography
TTE : Transthoracic Echocardiography
TVI : Time velocity Integral
VC : Vennacontracta
Prosthetic Heart Valves (PHV) is increasingly implanted in the world to replace diseased native valves. The dysfunction of the prosthetic valve remains a very serious complication with high mortality and morbidity. In clinical practice, transthoracic echocardiography and transesophageal echocardiography are the routine imaging modalities to evaluate the function of PHV. The aim of our study was to describe the echocardiographic aspects of dysfunction of valvular prostheses.
Materials and Methods
This is a retrospective study, which collected all patients admitted for dysfunction of mechanical prosthesis bileaflet in the cardiology department of Marrakech during a period of 2 years. Transthoracic studies included M-mode, two-dimensional, Doppler color flow imaging as well as pulsed and continuous wave Doppler modalities, performed with a 2.5-MHz transducer from standard echo windows.
Color Doppler was used for screening and evaluating the degree of intra- and/or paraprosthetic regurgitation.
Doppler-derived parameters of PHV function included peak velocity, Mean Pressure Gradient (MPG), and velocity-time integral of the jet by continuous-wave Doppler performed from apical. Prosthetic Effective Orifice Area (EOA) was derived from the continuity equation. A Doppler Velocity Index (DVI) was also calculated as the ratio between the proximal velocity-time integral in the LVOT and the velocity-time integral through the prosthesis valve. For TEE, monoplane 3.5 and 5.0 MHz phased-array transducers mounted at the tip of a modified gastro scope were used. All TEE was performed after administration of a local pharyngeal anesthetic without additional premeditation. Patients fasted for 4 hours and were examined in right lateral decubitus position without complications. All TEE was performed primarily for diagnostic
reasons. Informed consent was obtained from all patients before the examination. Echocardiographic criteria allow dysfunction diagnosis are summarized in [Table 1-3] [1].
Discussion
Prosthetic valve dysfunction is one of the most serious complications after mechanical valve replacement. In literature, the incidence was 0.1%-6% per patient year and the mean interval between the initial valve replacement and reoperation was 10–16 years [2].
Owing to its versatile, non-invasive, radiation-free, and low cost nature, Doppler echocardiography is undoubtedly the method of choice to evaluate prosthetic valve function. This evaluation follows the same principles used for the evaluation of native valves, with some important specifics. A complete echocardiography includes two dimensional imaging of the prosthetic valve, evaluation of valve leaflet/occluder morphology and mobility, presence of thrombus or vegetation, measurement of the transprosthetic gradients and EOA, estimation of the degree of regurgitation.
Leaflet morphology, mobility and etiology of PHV dysfunction:
Prosthetic valve stenosis is generally associated with abnormal valve morphology and/or mobility. TTE imaging of the valve occlude is often difficult to obtain because of reverberations and shadowing caused by the prosthetic valve components. TEE can provide improved image quality and thereby improved detection of the etiology of PHV dysfunction: leaflet calcification and thickening, vegetation, thrombus or pannus [3].
Quantitative parameters
Quantitative parameters of prosthetic valve function include transprosthetic flow velocity and pressure gradients, valve EOA, and DVI.
Transprosthetic velocity and gradient:
The high velocity or gradient alone is not proof of intrinsic prosthetic obstruction and may be secondary to prosthesise patient mismatch, high flow conditions, prosthetic valve regurgitation, or localized high central jet velocity in bileaflet mechanical valves.
Effective orifice area:
The EOA of prosthetic aortic valves is calculated with the continuity equation, based on the left ventricular outflow tract (LVOT) diameter, the time velocity integral (TVI) obtained by pulsed wave Doppler in the LVOT, and TVI obtained by continuous wave Doppler through the valve prosthesis. The EOA is reduced in case of obstruction of the prosthesis.
Doppler velocity index:
The DVI is a dimensionless ratio of the proximal flow velocity in the LVOT to the flow velocity through the aortic prosthesis. TVI may also be used in place of peak velocities to calculate DVI. These parameters can be helpful to screen for valve obstruction, particularly when the cross-sectional area of the LVOT cannot be obtained.
Detection and quantification of prosthetic valve regurgitation: It is important to separate physiologic from pathologic prosthesis regurgitation. Mechanical prostheses have a normal Regurgitant volume known as leakage backflow. As opposed to the pathologic Regurgitant jets, the normal leakage backflow jets are characterized by being short in duration, narrow, and symmetrical. In the case of pathologic regurgitation, it is also important to distinguish paravalvular from transvalvular regurgitation.
TOE is more sensitive in detecting the origin of the Regurgitant jets, the mechanism of regurgitation and the associated complications such as presence of pannus, thrombus, vegetation or masses interacting with occlude closure, abscess formation, or prosthesis dehiscence [4].
Indeed, TEE, especially 3-dimensional TEE, is the best diagnostic tool, which can define the causes better and helps in guiding therapy, risk stratification and monitoring follow-up outcomes.
This improved visualization by TEE can be explained by the following: The unobstructed view provided by close approximation of the esophagus to the heart; the ability to use higher frequency transducers, enabling the visualization of even small masses or masses with low echogenicity; and the ability to evaluate the atrial surface of devices in the mitral position [5].
Conclusion
Echocardiography is the gold standard for the diagnosis of prosthetic dysfunction with superiority of TEE over TTE. Hence, TEE should be systematically performed when there is a clinical or TTE suspicion of PHV dysfunction.
Figure 1: Color Doppler images of mitral Para-prosthesis regurgitation. A thrombus in one case [Figure 2].
Figure 2: Thrombus image on the mitral prosthesis. An anomaly of the movements of leaflet (18%). The Echo- Transesophageal (TEE) made in 8 patients, objectified images of thrombi (3 cases), paraprosthetic leaks (6 patients), abnormal of the movements of leaflet (4 cases) [Table 4].
|
Possible stenosis |
Significant stenosis |
||
aortic |
mitral |
aortic |
mitral |
|
Valve structure and motion |
Often abnormal |
Often abnormal |
abnormal |
abnormal |
Peak velocity m/s |
3-4 |
1.9 – 2.5 |
> 4 |
>2.5 |
Mean gradient (mmHg) |
20 -35 |
6-10 |
>35 |
>10 |
Doppler velocity index |
0.25 -0.29 |
2.2 -2.5 |
<0.25 |
>2.5 |
Effective orifice area (cm²) |
0.8 -1.2 |
1 -2 |
<0.8 |
<1 |
Pressure half time (ms) |
- |
130 -200 |
- |
>200 |
Table 1: Doppler echocardiography criteria for detection and quantification of valve stenos.
|
mild |
moderate |
severe |
LV size |
normal |
normal or dilated |
dilated |
Valve structure and motion |
normal |
abnormal |
abnormal |
Color flow jet area |
<4cm² |
variable |
>8cm² |
VC (cm) |
<0.3 |
0.3 -0.59 |
>0.6 |
R vol (ml/beat) |
<30 |
30 -59 |
>60 |
EROA (cm²) |
<0.20 |
0.20 -0.49 |
>50 |
Pulmonary venous flow |
Systolic dominance |
Systolic blunting |
Systolic |
EROA: Effective Regurgitant Orifice Area, R vol: Regurgitant volume, VC: vena contracta.
Table 2: Echocardiography and Doppler criteria for severity of prosthesis mitral regurgitation.
|
mild |
moderate |
severe |
LV size |
normal |
normal or dilated |
dilated |
Valve structure and motion |
normal |
abnormal |
abnormal |
VC (cm) |
<0.3 |
0.3 -0.59 |
>0.6 |
R vol (ml/beat) |
<30 |
30 -59 |
>60 |
PHT (ms) |
>500 |
200-500 |
<200 |
Diastolic flow reversal in the ascending aorta |
<10 |
10-20 |
>20 |
Table 3: Echocardiography and Doppler criteria for severity of prosthesis aortic regurgitation.
|
TTE (N=11) |
TEE (N=8) |
|||
Mitral prosthesis N=6 cases |
anomaly of the movements of leaflet |
2 cases |
|
2 cases |
|
increased gradient |
3 cases |
14+/-2mmHg |
|
||
paraprosthetic leak |
3 cases |
|
3 cases |
||
decreased EOA |
3cases |
1.2+/-0.3 mm² |
|
||
PHT decreased |
5 cases |
190+/-15ms |
|
||
Thrombus |
1 case |
|
2 cases |
||
Vegetation |
0 |
|
3 cases |
||
Aortic prosthesis N=6 cases |
anomaly of the movements of leaflet |
0 |
|
2 cases |
|
increased gradient |
3cases |
32+/-2mmHg |
|
||
paraprosthetic leak |
2 cases |
|
3 cases |
||
decreased EOA |
3 cases |
0.8 +/-0.15mm² |
|
||
DVI decreased |
3 cases |
0.24+/-0.03 |
|
||
Thrombus |
0 |
|
1 case |
Table 4: Echocardiography data of patients.
- Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, et al. (2009) “GUIDELINES AND STANDARDS” Recommendations for Evaluation of Prosthetic Valves with Echocardiography and Doppler Ultrasound. Journal of the American Society of Echocardiography 22: 975-1014.
- Wei-Guo, Ma WG, Abdurusul A, Gong DX, Tang Y, et al. (2015) Dysfunction of mechanical heart valve prosthesis: experience with surgical management in 48 patients. Journal of Thoracic Disease 7: 2321-2329.
- Werner G, Mügge A, Grote J, Hausmann D, Nikutta P, et al. (1993) Comparison of Transthoracic and Transesophageal Echocardiography for Detection of Abnormalities of Prosthetic and Bioprosthetic Valves in the Mitral and Aortic Positions. THE AMERICAN JOURNAL OF CARDIOLOGY 71: 210-215.
- Daniel LB, Grigg LE, Weisel RD, Rakowski H (1990) Comparison of transthoracic and transesophageal assessment of prosthetic valve dysfunction. Echocardiography 7: 83-95.
- Bach DS (2000) Transesophageal Echocardiographic (TEE) evaluation of Prosthetic Valves. Cardiol Clin 18: 751-771.